Future Directions in research on Betel Leaf and Diabetes Management

When insulin production or action is impaired, a metabolic condition known as diabetes mellitus (DM) sets up, causing persistently high blood sugar levels. By 2025, diabetes will have impacted an estimated 300 million people worldwide, according to the World Health Organisation. Insulin and oral hypoglycemic medications are examples of current treatments that can cause unwanted side effects. Traditional betel leaf, or Piper betle L., has antidiabetic effects, and this research investigates such effects. This study compares the effects of betel leaf juice to those of metformin, a popular antidiabetic drug, on lipid profiles, liver enzymes & blood glucose.